Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Short term Debt (2020 - 2025)

Historic Short term Debt for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $5.4 million.

  • Maravai Lifesciences Holdings' Short term Debt changed 0.0% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.4 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Short term Debt of $5.4 million as of Q3 2025, which was down 0.0% from $5.4 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Short term Debt high stood at $42.3 million for Q1 2023, and its period low was $5.4 million during Q4 2022.
  • In the last 5 years, Maravai Lifesciences Holdings' Short term Debt had a median value of $5.4 million in 2022 and averaged $13.6 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Short term Debt soared by 48063.33% in 2021 and then plummeted by 8712.55% in 2024.
  • Maravai Lifesciences Holdings' Short term Debt (Quarter) stood at $34.8 million in 2021, then tumbled by 84.38% to $5.4 million in 2022, then changed by 0.0% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $5.4 million for Q2 2025, and $5.4 million during Q1 2025.